NCT02582697 Accelerated v's Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell Tumours Status RECRUITING Phase PHASE3
NCT02581384 Stereotactic Body Radiotherapy (SBRT) for Pulmonary Metastases in Ewing Sarcoma, Rhabdomyosarcoma, and Wilms Tumors Status TERMINATED Phase PHASE1/PHASE2
NCT02537613 A Study of Ibrutinib + Obinutuzumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT02520713 The iCat2, GAIN (Genomic Assessment Informs Novel Therapy) Consortium Study Status ACTIVE_NOT_RECRUITING Phase N/A
NCT02514824 MLN0128 in Recurrent/Metastatic Merkel Cell Carcinoma Status COMPLETED Phase PHASE1/PHASE2
NCT02502695 A Study to Optimize Care for Lung Cancer Patients Undergoing Video-Assisted Thoracoscopic Surgery (VATS) Status COMPLETED Phase N/A
NCT02499497 A Selective Androgen Receptor Modulator for Symptom Management in Prostate Cancer Status COMPLETED Phase PHASE2
NCT02489617 The Incidence of Adjacent Synchronous Ipsilateral Infiltrating Carcinoma and/or DCIS in Patients Diagnosed With Intraductal Papilloma Without Atypia or Flat Epithelial Atypia by Core Needle Biopsy Status COMPLETED Phase NA
NCT02478164 Trial of Ponatinib in Patients With Bevacizumab-Refractory Glioblastoma Status COMPLETED Phase PHASE2
NCT02474368 Study Evaluating a Stereotactic Boost/Treatment for Recurrent or Metastatic Cancer of the Head and Neck Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT02470910 Incorporating MR Imaging Into Prostate Radiotherapy Treatment Planning Status COMPLETED Phase NA
NCT02466061 TREC Lifestyle Beyond Cancer Study in Endometrial Cancer Survivors Status COMPLETED Phase NA
NCT02452710 Harnessing the Effect of an Open-Label Placebo on Fatigue in Cancer Survivors Status TERMINATED Phase NA
NCT02450708 Selection of Allogeneic Hematopoietic Cell Donors Based on KIR and HLA Genotypes Status ACTIVE_NOT_RECRUITING Phase NA
NCT02448771 A Study of Palbociclib in Combination With Bazedoxifene in Hormone Receptor Positive Breast Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT02448537 A Phase II Multi-Strata Study of PM01183 as a Single Agent or in Combination With Conventional Chemotherapy in Metastatic and/or Unresectable Sarcomas Status COMPLETED Phase PHASE2
NCT02441686 Phase II Study of Efficacy and Safety of Lenalidomide, Subcutaneous Bortezomib and Dexamethasone Therapy for Newly Diagnosed Multiple Myeloma Status COMPLETED Phase PHASE2
NCT02441140 Detection of Tumor Associated Cell-free DNA in Peritoneal Fluid Obtained by Culdocentesis Status TERMINATED Phase NA